Overview

Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

Status:
Completed

Trial end date:
2018-10-12

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effect of vonoprazan compared to esomeprazole for preventing heartburn symptoms over a 4-week treatment period in participants who have a partial response to treatment with esomeprazole.

Phase:

Phase 2

Details

Lead Sponsor:

Takeda

Treatments:

Esomeprazole
Proton Pump Inhibitors